US|EN
Select your region & language
Our content and services may vary by location.
US|EN
Back
Smiling employee in a conversation with a colleague in the office
Smiling employee in a conversation with a colleague in the office
ID: 130842

Medical Expert

  • Pharma & Biotech
  • Asap
  • KOL Management, Team Building, Sales & Team Coach
  • K-Recruiting Schweiz AG
Contact:

Julius Strack

+49 89 1890998-21

julius.strack@k-recruiting.com

Overview

Availability
Asap; full-time; onsite & remote
Qualification
PhD in Biology (Dr. rer. nat.), University
Language Skills
German (native), English (business fluent)
Relevant Expertise
Relevant Expertise (Senior) MSL, Medical Affairs, KOL Management, Team Building, Sales & Team Coach, Strategic & Operational Support, Oncology, Biomarker, Rare Disease, Pharma, Biotech

Key-Facts

  • With extensive experience as a Senior MSL in Oncology, this consultant has a strong passion for the field and consistently demonstrates the ability to lead and inspire teams

  • Combining scientific expertise with strategic thinking, this professional positions products effectively and drives their success, supported by hands-on experience with various products

  • A strong ability to rapidly build reliable and lasting relationships makes this consultant an excellent leader, networker, and motivator within teams, helping to successfully advance projects

  • Brings extensive experience across multiple disease areas and work settings, including pre-launch, launch, and post-launch phases, with a focus on Neurosciences, Rare Diseases, and Oncology

  • Both professionally and personally, this consultant is a real asset to any medical project

Extract from Previous Activities

2025 – Date

Pharma Company, Switzerland (via K-Recruiting)

MSL & Medical Manager Oncology

  • Implementation of preparatory measures for a potential product launch

  • Establishing contact with study centres, including on-site visits

  • Field analysis of patient location and other medical study information

  • Structuring and preparation of results for meaningful presentation slides

  • Focus on oncology, particularly paediatric oncology

2023 – 2024

Biotech Company, Switzerland

International Medical Science Liaison

  • Strategic and operational support

  • Interface between diagnostic and therapeutic

  • Genomic Expression Profiling Tests in Oncology

2022 – Date

Biopharmaceutical Company, Switzerland

Medical Science Liaison DACH

  • Establish relationships with stakeholders and opinion leaders

  • Rare & ultra rare diseases (Neuroblastoma and Castleman´s disease – tumor of the central nervous system in children and inflammatory lymph node disease)

  • Support clinical trials; center support

  • Presence at national/global congresses, data dissemination internally and externally

  • Oncology products in rare diseases (neuroblastoma - pediatric oncology & Castleman's disease)

  • Co-development and implementation of strategy

2022 – 2024

Biotech Company, Switzerland

Medical Advisor DACH

  • Develop and establish resilient networks with the stakeholders of the community

  • Medical-scientific support for market preparation of innovative products for rare eye diseases

  • Providing scientific information

  • Medical validation of educational and promotional materials

  • Work closely with cross-functional medical and marketing teams and cover multiple countries/regions

2017 – 2021

Pharmaceutical Company, Switzerland

Medical Expert Rare Disease

  • Responsible for connecting to patients and all stakeholders around patients i.e. patient advocacy groups, caregivers, healthcare physicians, study investigators, but also policy stakeholders

  • Explore needs and set up projects, networks and determine strategy to shape the system to get ready for a possible launch of a diseases modifying treatment